The role of caveolae in the pathophysiology of lung diseases

References

• Collard HR, Ward AJ, Lanes S, Cortney Hayflinger D, Rosenberg DM, Hunsche E. Burden of illness in idiopathic pulmonary fibrosis. J. Med. Econ. 15(5), 829–835 (2012).
   PubMedGoogle Scholar
• Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest 117(2 Suppl.), 1S–4S (2000).
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med. 163(5), 1256–1276 (2001).
   PubMedGoogle Scholar
• Hanania NA, King MJ, Braman SS et al. Asthma in the elderly: Current understanding and future research needs – a report of a National Institute on Aging (NIA) workshop. J. Allergy. Clin. Immunol. 128(3 Suppl.), S4–24 (2011).
   PubMed Web of Science ®Google Scholar
• Maniatis NA, Chernaya O, Shinin V, Minshall RD. Caveolins and lung function. Adv. Exp. Med. Biol. 729, 157–179 (2012).
   Google Scholar
• Gosens R, Mutawe M, Martin S et al. Caveolae and caveolins in the respiratory system. Curr. Mol. Med. 8(8), 741–753 (2008).
   Google Scholar
• Prakash YS, Thompson MA, Vaa B et al. Caveolins and intracellular calcium regulation in human airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 293(5), L1118–1126 (2007).
   PubMed Web of Science ®Google Scholar
• Gratton J-P, Bernatchez P, Sessa WC. Caveolae and Caveolins in the Cardiovascular System. Circ. Res. 94(11), 1408–1417 (2004).
   PubMed Web of Science ®Google Scholar
• Williams TM. The Caveolin genes: from cell biology to medicine. Ann. Med. 36(8), 584–595 (2004).
   PubMed Web of Science ®Google Scholar
• Williams TM, Lisanti MP. The caveolin proteins. Genome Biol. 5(3), 214 (2004).
   PubMed Web of Science ®Google Scholar
• Palade G. Fine structure of blood capillaries. J. Appl. Physiol. 24, 1424–1429 (1953).
   Web of Science ®Google Scholar
• Yamada E. The fine structure of the gall bladder epithelium of the mouse. J. Biophys. Biochem. Cytol. 1(5), 445–458 (1955).
   PubMedGoogle Scholar
• Sathish V, Abcejo AJ, Thompson MA, Sieck GC, Prakash YS, Pabelick CM. Caveolin-1 regulation of store-operated Ca(2+) influx in human airway smooth muscle. Eur. Respir. J. 40(2), 470–478 (2012).
   PubMed Web of Science ®Google Scholar
• Sathish V, Abcejo AJ, Vanoosten SK, Thompson MA, Prakash YS, Pabelick CM. Caveolin-1 in Cytokine-Induced Enhancement of Intracellular Ca2+ in Human Airway Smooth Muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 301(4), L607–614 (2011).
   PubMed Web of Science ®Google Scholar
• Schlegel A, Arvan P, Lisanti MP. Caveolin-1 binding to endoplasmic reticulum membranes and entry into the regulated secretory pathway are regulated by serine phosphorylation. Protein sorting at the level of the endoplasmic reticulum. J. Biol. Chem. 276(6), 4398–4408 (2001).
   PubMedGoogle Scholar
• Schlegel A, Schwab RB, Scherer PE, Lisanti MP. A role for the caveolin scaffolding domain in mediating the membrane attachment of caveolin-1. The caveolin scaffolding domain is both necessary and sufficient for membrane binding in vitro. J. Biol. Chem. 274(32), 22660–22667 (1999).
   Google Scholar
• Cohen AW, Hnasko R, Schubert W, Lisanti MP. Role of caveolae and caveolins in health and disease. Physiol. Rev. 84(4), 1341–1379 (2004).
   PubMed Web of Science ®Google Scholar
• Brott D, Gould S, Jones H et al. Biomarkers of drug-induced vascular injury. Toxicol. Appl. Pharmacol. 207(2 Suppl.), 441–445 (2005).
   Google Scholar
• Thomas CM, Smart EJ. Caveolae structure and function. J. Cell Mol. Med. 12(3), 796–809 (2008).
   PubMed Web of Science ®Google Scholar
• Head BP, Patel HH, Tsutsumi YM et al. Caveolin-1 expression is essential for N-methyl-D-aspartate receptor-mediated Src and extracellular signal-regulated kinase 1/2 activation and protection of primary neurons from ischemic cell death. FASEB J. 22(3), 828–840 (2008).
   Google Scholar
• Gosens R, Stelmack GL, Dueck G et al. Caveolae facilitate muscarinic receptor-mediated intracellular Ca2+ mobilization and contraction in airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 293(6), L1406–1418 (2007).
   PubMed Web of Science ®Google Scholar
• Sommer B, Montano LM, Carbajal V et al. Extraction of membrane cholesterol disrupts caveolae and impairs serotonergic (5-HT2A) and histaminergic (H1) responses in bovine airway smooth muscle: role of Rho-kinase. Can. J. Physiol. Pharmacol. 87(3), 180–195 (2009).
   Google Scholar
• Hnasko R, Lisanti MP. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease. Mol. Interv. 3(8), 445–464 (2003).
   Google Scholar
• Frank PG, Woodman SE, Park DS, Lisanti MP. Caveolin, caveolae, and endothelial cell function. Arterioscler. Thromb. Vasc. Biol. 23(7), 1161–1168 (2003).
   PubMed Web of Science ®Google Scholar
• Razani B, Lisanti MP. Caveolin-deficient mice: insights into caveolar function human disease. J. Clin. Invest. 108(11), 1553–1561 (2001).
   Google Scholar
• Schlegel A, Lisanti MP. The caveolin triad: caveolae biogenesis, cholesterol trafficking, and signal transduction. Cytokine Growth Factor Rev. 12(1), 41–51 (2001).
   Google Scholar
• Scherer PE, Lewis RY, Volonté D et al. Cell-type and Tissue-specific Expression of Caveolin-2: Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J. Biol. Chem. 272(46), 29337–29346 (1997).
   PubMed Web of Science ®Google Scholar
• Song KS, Scherer PE, Tang Z et al. Expression of Caveolin-3 in Skeletal, Cardiac, and Smooth Muscle Cells: Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J. Biol. Chem. 271(25), 15160–15165 (1996).
   PubMed Web of Science ®Google Scholar
• Maniatis NA, Shinin V, Schraufnagel DE et al. Increased pulmonary vascular resistance and defective pulmonary artery filling in caveolin-1-/- mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 294(5), L865–873 (2008).
   PubMed Web of Science ®Google Scholar
• Sowa G. Caveolae, caveolins, cavins, and endothelial cell function: new insights. Front. Physiol. 2, 120 (2012).
   Google Scholar
• Sun Y, Minshall RD, Hu G. Role of caveolin-1 in the regulation of pulmonary endothelial permeability. Methods Mol. Biol. 763, 303–317 (2011).
   Google Scholar
• Huang J, Wolk JH, Gewitz MH, Mathew R. Caveolin-1 expression during the progression of pulmonary hypertension. Exp. Biol. Med. (Maywood), 237(8), 956–965 (2012).
   PubMed Web of Science ®Google Scholar
• Sathish V, Yang B, Meuchel LW et al. Caveolin-1 and force regulation in porcine airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 300(6), L920–929 (2011).
   PubMed Web of Science ®Google Scholar
• Gosens R, Stelmack GL, Bos ST et al. Caveolin-1 is required for contractile phenotype expression by airway smooth muscle cells. J. Cell. Mol. Med. 15(11), 2430–2442 (2010).
   Google Scholar
• de Almeida CJ, Jasmin JF, Del Galdo F, Lisanti MP. Genetic ablation of caveolin-2 sensitizes mice to bleomycin-induced injury. Cell Cycle 12(14) (2013).
   Google Scholar
• Xie L, Vo-Ransdell C, Abel B, Willoughby C, Jang S, Sowa G. Caveolin-2 is a negative regulator of anti-proliferative function and signaling of transforming growth factor-beta in endothelial cells. Am. J. Physiol. Cell. Physiol. 301(5), C1161–1174 (2011).
   Google Scholar
• Doyle DD, Upshaw-Earley J, Bell E, Clive Palfrey H. Expression of caveolin-3 in rat aortic vascular smooth muscle cells is determined by developmental state. Biochem. Biophys. Res. Commun. 304(1), 22–25 (2003).
   Google Scholar
• Segal SS, Brett SE, Sessa WC. Codistribution of NOS and caveolin throughout peripheral vasculature and skeletal muscle of hamsters. Am. J. Physiol. 277(3 Pt 2), H1167–H1177 (1999).
   Google Scholar
• Chidlow JH, Jr., Sessa WC. Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation. Cardiovasc. Res. 86(2), 219–225 (2010).
   PubMed Web of Science ®Google Scholar
• Hansen CG, Nichols BJ. Exploring the caves: cavins, caveolins and caveolae. Trends Cell Biol. 20(4), 177–186 (2010).
   PubMed Web of Science ®Google Scholar
• Nabi IR. Cavin fever: regulating caveolae. Nat. Cell Biol. 11(7), 789–791 (2009).
   PubMed Web of Science ®Google Scholar
• Hill MM, Bastiani M, Luetterforst R et al. PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 132(1), 113–124 (2008).
   PubMed Web of Science ®Google Scholar
• Liu L, Pilch PF. A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization. J. Biol. Chem. 283(7), 4314–4322 (2008).
   PubMed Web of Science ®Google Scholar
• Jansa P, Mason SW, Hoffmann-Rohrer U, Grummt I. Cloning and functional characterization of PTRF, a novel protein which induces dissociation of paused ternary transcription complexes. EMBO J. 17(10), 2855–2864 (1998).
   Google Scholar
• Jansa P. Mechanism of transcription termination:PTRF interacts with the largest subunit of RNA polymerase I and dissociates paused transcription complexes from yeast and mouse. Mol. Gen. Genet. 262(3), 508–5014 (1999).
   Google Scholar
• Hardin CD, Vallejo J. Caveolins in vascular smooth muscle: Form organizing function. Cardiovasc. Res. 69(4), 808–815 (2006).
   Google Scholar
• Byrne S, Cheent A, Dimond J, Fisher G, Ockleford CD. Immunocytochemical localization of a caveolin-1 isoform in human term extra-embryonic membranes using confocal laser scanning microscopy: implications for the complexity of the materno-fetal junction. Placenta 22(6), 499–510 (2001).
   Google Scholar
• Silva WI, Maldonado HM, Lisanti MP et al. Identification of caveolae and caveolin in C6 glioma cells. Int. J. Dev. Neurosci. 17(7), 705–714 (1999).
   Google Scholar
• Jin Y, Lee SJ, Minshall RD, Choi AM. Caveolin-1: a critical regulator of lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 300(2), L151–160 (2011).
   PubMed Web of Science ®Google Scholar
• Shivshankar P, Brampton C, Miyasato S, Kasper M, Thannickal VJ, Le Saux CJ. Caveolin-1 deficiency protects from pulmonary fibrosis by modulating epithelial cell senescence in mice. Am. J. Respir. Cell Mol. Biol. 47(1), 28–36 (2012).
   PubMed Web of Science ®Google Scholar
• Sharma P, Ghavami S, Stelmack GL et al. beta-Dystroglycan binds caveolin-1 in smooth muscle: a functional role in caveolae distribution and Ca2+ release. J. Cell Sci. 123(Pt 18), 3061–3070 (2010).
   Google Scholar
• Aravamudan B, Vanoosten SK, Meuchel LW et al. Caveolin-1 knockout mice exhibit airway hyperreactivity. Am. J. Physiol. Lung Cell. Mol. Physiol. 303(8), L669–681 (2012).
   PubMed Web of Science ®Google Scholar
• Engelman JA, Zhang XL, Razani B, Pestell RG, Lisanti MP. p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression. Activation of Ras-MAP kinase and protein kinase a signaling cascades transcriptionally down-regulates caveolin-1 promoter activity. J. Biol. Chem. 274(45), 32333–32341 (1999).
   PubMed Web of Science ®Google Scholar
• Liu J, Razani B, Tang S, Terman BI, Ware JA, Lisanti MP. Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1. J. Biol. Chem. 274(22), 15781–15785 (1999).
   Google Scholar
• Park WY, Cho KA, Park JS, Kim DI, Park SC. Attenuation of EGF signaling in senescent cells by caveolin. Ann. NY Acad. Sci. 928, 79–84 (2001).
   Google Scholar
• Razani B, Wang XB, Engelman JA et al. Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Mol. Cell Biol. 22(7), 2329–2344 (2002).
   PubMedGoogle Scholar
• Smart EJ, Graf GA, McNiven MA et al. Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell Biol. 19(11), 7289–7304 (1999).
   PubMedGoogle Scholar
• Bist A, Fielding PE, Fielding CJ. Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. Proc. Natl Acad. Sci. USA 94(20), 10693–10698 (1997).
   Google Scholar
• Fielding CJ, Bist A, Fielding PE. Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. Proc. Natl Acad. Sci. USA 94(8), 3753–3758 (1997).
   PubMed Web of Science ®Google Scholar
• Frank PG, Galbiati F, Volonte D et al. Influence of caveolin-1 on cellular cholesterol efflux mediated by high-density lipoproteins. Am. J. Physiol. Cell Physiol. 280(5), C1204–1214 (2001).
   Google Scholar
• Volonte D, Galbiati F. Caveolin-1, cellular senescence and pulmonary emphysema. Aging 1(9), 831–835 (2009).
   PubMedGoogle Scholar
• Zou H, Stoppani E, Volonte D, Galbiati F. Caveolin-1, cellular senescence and age-related diseases. Mech. Ageing Dev. 132(11–12), 533–542 (2011).
   PubMed Web of Science ®Google Scholar
• Hamoudane M, Maffioli S, Cordera R, Maggi D, Salani B. Caveolin-1 and polymerase I and transcript release factor: new players in insulin-like growth factor-I receptor signaling. J. Endocrinol. Invest. 36(3), 204–208 (2013).
   Google Scholar
• Govender P, Romero F, Shah D et al. Cavin1; a regulator of lung function and macrophage phenotype. PLoS ONE 8(4), e62045 (2013).
   Google Scholar
• Wang Y, Roche O, Xu C et al. Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1. Proc. Natl Acad. Sci. USA 109(13), 4892–4897 (2012).
   Google Scholar
• Orlichenko L, Weller SG, Cao H et al. Caveolae mediate growth factor-induced disassembly of adherens junctions to support tumor cell dissociation. Mol. Biol. Cell 20(19), 4140–4152 (2009).
   Google Scholar
• Matveev SV, Smart EJ. Heterologous desensitization of EGF receptors and PDGF receptors by sequestration in caveolae. Am. J. Physiol. Cell Physiol. 282(4), C935–946 (2002).
   Google Scholar
• Gosens R, Stelmack GL, Dueck G et al. Role of caveolin-1 in p42/p44 MAP kinase activation and proliferation of human airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 291(3), L523–534 (2006).
   PubMed Web of Science ®Google Scholar
• Fujita Y, Maruyama S, Kogo H, Matsuo S, Fujimoto T. Caveolin-1 in mesangial cells suppresses MAP kinase activation and cell proliferation induced by bFGF and PDGF. Kidney Int. 66(5), 1794–1804 (2004).
   PubMedGoogle Scholar
• Huang CS, Zhou J, Feng AK et al. Nerve growth factor signaling in caveolae-like domains at the plasma membrane. J. Biol. Chem. 274(51), 36707–36714 (1999).
   Google Scholar
• Bilderback TR, Gazula VR, Lisanti MP, Dobrowsky RT. Caveolin interacts with Trk A and p75(NTR) and regulates neurotrophin signaling pathways. J. Biol. Chem. 274(1), 257–263 (1999).
   Google Scholar
• Yang T, Massa SM, Longo FM. LAR protein tyrosine phosphatase receptor associates with TrkB and modulates neurotrophic signaling pathways. J. Neurobiol. 66(13), 1420–1436 (2006).
   Google Scholar
• Daniel EE, Eteraf T, Sommer B, Cho WJ, Elyazbi A. The role of caveolae and caveolin 1 in calcium handling in pacing and contraction of mouse intestine. J. Cell Mol. Med. 13(2), 352–364 (2009).
   Google Scholar
• Pojoga LH, Adamová Z, Kumar A et al. Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 298(6), H1776–H1788 (2010).
   Google Scholar
• Poljakovic M, Porter DW, Millecchia L et al. Cell- and isoform-specific increases in arginase expression in acute silica-induced pulmonary inflammation. J. Toxicol. Environ. Health A 70(2), 118–127 (2007).
   PubMed Web of Science ®Google Scholar
• Hunter I, Nixon GF. Spatial compartmentalization of tumor necrosis factor (TNF) receptor 1-dependent signaling pathways in human airway smooth muscle cells. Lipid rafts are essential for TNF-alpha-mediated activation of RhoA but dispensable for the activation of the NF-kappaB and MAPK pathways. J. Biol. Chem. 281(45), 34705–34715 (2006).
   Google Scholar
• Sakai H, Kurihara Y, Hashimoto Y, Chiba Y, Misawa M. Involvement of multiple PKC isoforms in phorbol 12,13-dibutyrate-induced contraction during high K(+) depolarization in bronchial smooth muscle of mice. J. Smooth Muscle Res. 46(5), 225–233 (2010).
   Google Scholar
• Bai Y, Edelmann M, Sanderson MJ. The contribution of inositol 1,4,5-trisphosphate and ryanodine receptors to agonist-induced Ca(2+) signaling of airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 297(2), L347–361 (2009).
   Google Scholar
• Ali NK, Jafri A, Sopi RB, Prakash YS, Martin RJ, Zaidi SI. Role of arginase in impairing relaxation of lung parenchyma of hyperoxia-exposed neonatal rats. Neonatology 101(2), 106–115 (2011).
   Google Scholar
• Zhao YY, Malik AB. A novel insight into the mechanism of pulmonary hypertension involving caveolin-1 deficiency and endothelial nitric oxide synthase activation. Trends Cardiovasc. Med. 19(7), 238–242 (2009).
   Google Scholar
• Ryter SW, Choi AM. Caveolin-1: a critical regulator of pulmonary vascular architecture and nitric oxide bioavailability in pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 294(5), L862–864 (2008).
   PubMed Web of Science ®Google Scholar
• Grayson TH, Chadha PS, Bertrand PP et al. Increased caveolae density and caveolin-1 expression accompany impaired NO-mediated vasorelaxation in diet-induced obesity. Histochem. Cell Biol. 139(2), 309–321 (2013).
   Google Scholar
• Garcia-Cardena G, Oh P, Liu J, Schnitzer JE, Sessa WC. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc. Natl Acad. Sci. USA 93(13), 6448–6453 (1996).
   Google Scholar
• Ju H, Zou R, Venema VJ, Venema RC. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J. Biol. Chem. 272(30), 18522–18525 (1997).
   PubMed Web of Science ®Google Scholar
• de Weerd WFC, Leeb-Lundberg LMF. Bradykinin Sequesters B2 Bradykinin Receptors and the Receptor-coupled Gα Subunits Gαq and Gαiin Caveolae in DDT1 MF-2 Smooth Muscle Cells. J. Biol. Chem. 272(28), 17858–17866 (1997).
   Google Scholar
• Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. Am. J. Respir. Crit. Care Med. 161(5), 1720–1745 (2000).
   PubMed Web of Science ®Google Scholar
• Garrean S, Gao XP, Brovkovych V et al. Caveolin-1 regulates NF-kappaB activation and lung inflammatory response to sepsis induced by lipopolysaccharide. J. Immunol. 177(7), 4853–4860 (2006).
   PubMed Web of Science ®Google Scholar
• Volonte D, Kahkonen B, Shapiro S, Di Y, Galbiati F. Caveolin-1 expression is required for the development of pulmonary emphysema through activation of the ATM-p53-p21 pathway. J. Biol. Chem. 284(9), 5462–5466 (2009).
   PubMed Web of Science ®Google Scholar
• Murphy DM, O'Byrne PM. Recent advances in the pathophysiology of asthma. Chest J. 137(6), 1417–1426 (2010).
   PubMed Web of Science ®Google Scholar
• Hotta K, Emala CW, Hirshman CA. TNF-α upregulates Giα and Gqα protein expression and function in human airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 276(3), L405–L411 (1999).
   Google Scholar
• Oenema T, Kolahian S, Nanninga J et al. Pro-inflammatory mechanisms of muscarinic receptor stimulation in airway smooth muscle. Respir. Res. 11(1), 130 (2010).
   Google Scholar
• White TA, Xue A, Chini EN, Thompson M, Sieck GC, Wylam ME. Role of Transient Receptor Potential C3 in TNF-α–Enhanced Calcium Influx in Human Airway Myocytes. Am. J. Respir. Cell. Mol. Biol. 35(2), 243–251 (2006).
   Google Scholar
• Le Saux O, Teeters K, Miyasato S et al. The role of caveolin-1 in pulmonary matrix remodeling and mechanical properties. Am. J. Physiol. Lung Cell. Mol. Physiol. 295(6), L1007–1017 (2008).
   Google Scholar
• Shifren A, Witt C, Christie C, Castro M. Mechanisms of remodeling in asthmatic airways. J. Allergy (Cairo), 2012, 316049 (2012).
   Google Scholar
• James AL, Wenzel S. Clinical relevance of airway remodelling in airway diseases. Eur. Respir. J. 30(1), 134–155 (2007).
   PubMed Web of Science ®Google Scholar
• Hackett T-L, de Bruin HG, Shaheen F et al. Caveolin-1 controls airway epithelial barrier function: implications for asthma. Am. J. Respir. Cell. Mol. Biol. 49(4), 662–671 (2013).
   PubMed Web of Science ®Google Scholar
• Haines P, Samuel GH, Cohen H, Trojanowska M, Bujor AM. Caveolin-1 is a negative regulator of MMP-1 gene expression in human dermal fibroblasts via inhibition of Erk1/2/Ets1 signaling pathway. J. Dermatol. Sci. 64(3), 210–216 (2011).
   PubMed Web of Science ®Google Scholar
• Peterson TE, Guicciardi ME, Gulati R et al. Caveolin-1 can regulate vascular smooth muscle cell fate by switching platelet-derived growth factor signaling from a proliferative to an apoptotic pathway. Arterioscler. Thromb. Vasc. Biol. 23(9), 1521–1527 (2003).
   Google Scholar
• Faux SP, Tai T, Thorne D, Xu Y, Breheny D, Gaca M. The role of oxidative stress in the biological responses of lung epithelial cells to cigarette smoke. Biomarkers 14(Suppl. 1), 90–96 (2009).
   PubMedGoogle Scholar
• Zeng G, McCue HM, Mastrangelo L, Millis AJ. Endogenous TGF-beta activity is modified during cellular aging: effects on metalloproteinase and TIMP-1 expression. Exp. Cell Res. 228(2), 271–276 (1996).
   Google Scholar
• Maniatis NA, Kardara M, Hecimovich D et al. Role of caveolin-1 expression in the pathogenesis of pulmonary edema in ventilator-induced lung injury. Pulm. Circ. 2(4), 452–460 (2012).
   PubMedGoogle Scholar
• Sundivakkam PC, Kwiatek AM, Sharma TT, Minshall RD, Malik AB, Tiruppathi C. Caveolin-1 scaffold domain interacts with TRPC1 and IP3R3 to regulate Ca2+ store release-induced Ca2+ entry in endothelial cells. Am. J. Physiol. Cell Physiol. 296(3), C403–413 (2009).
   PubMed Web of Science ®Google Scholar
• Sun Y, Hu G, Zhang X, Minshall RD. Phosphorylation of caveolin-1 regulates oxidant-induced pulmonary vascular permeability via paracellular and transcellular pathways. Circ. Res. 105(7), 676–685 (2009).
   Google Scholar
• Ingbar DH. Mechanisms of repair and remodeling following acute lung injury. Clin. Chest Med. 21(3), 589–616 (2000).
   PubMed Web of Science ®Google Scholar
• Hu G, Vogel SM, Schwartz DE, Malik AB, Minshall RD. Intercellular adhesion molecule-1-dependent neutrophil adhesion to endothelial cells induces caveolae-mediated pulmonary vascular hyperpermeability. Circ. Res. 102(12), e120–131 (2008).
   PubMed Web of Science ®Google Scholar
• Hu G, Ye RD, Dinauer MC, Malik AB, Minshall RD. Neutrophil caveolin-1 expression contributes to mechanism of lung inflammation and injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 294(2), L178–186 (2008).
   PubMed Web of Science ®Google Scholar
• Franek WR, Horowitz S, Stansberry L et al. Hyperoxia inhibits oxidant-induced apoptosis in lung epithelial cells. J. Biol. Chem. 276(1), 569–575 (2001).
   Google Scholar
• Lee PJ, Alam J, Sylvester SL, Inamdar N, Otterbein L, Choi AM. Regulation of heme oxygenase-1 expression in vivo and in vitro in hyperoxic lung injury. Am. J. Respir. Cell. Mol. Biol. 14(6), 556–568 (1996).
   PubMed Web of Science ®Google Scholar
• Jin Y, Kim HP, Chi M, Ifedigbo E, Ryter SW, Choi AM. Deletion of caveolin-1 protects against oxidative lung injury via up-regulation of heme oxygenase-1. Am. J. Respir. Cell. Mol. Biol. 39(2), 171–179 (2008).
   PubMed Web of Science ®Google Scholar
• Zhang M, Lin L, Lee SJ et al. Deletion of caveolin-1 protects hyperoxia-induced apoptosis via survivin-mediated pathways. Am. J. Physiol. Lung Cell. Mol. Physiol. 297(5), L945–953 (2009).
   PubMed Web of Science ®Google Scholar
• Tourkina E, Hoffman S. Caveolin-1 signaling in lung fibrosis. Open Rheumatol. J. 6, 116–122 (2012).
   PubMedGoogle Scholar
• Del Galdo F, Lisanti MP, Jimenez SA. Caveolin-1, transforming growth factor-beta receptor internalization, and the pathogenesis of systemic sclerosis. Curr. Opin. Rheumatol. 20(6), 713–719 (2008).
   Google Scholar
• Razani B, Engelman JA, Wang XB et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276(41), 38121–38138 (2001).
   PubMed Web of Science ®Google Scholar
• Le Saux CJ, Teeters K, Miyasato SK et al. Down-regulation of caveolin-1, an inhibitor of transforming growth factor-beta signaling, in acute allergen-induced airway remodeling. J. Biol. Chem. 283(9), 5760–5768 (2008).
   PubMed Web of Science ®Google Scholar
• Wang XM, Zhang Y, Kim HP et al. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J. Exp. Med. 203(13), 2895–2906 (2006).
   PubMed Web of Science ®Google Scholar
• Tourkina E, Gooz P, Pannu J et al. Opposing effects of protein kinase Calpha and protein kinase Cepsilon on collagen expression by human lung fibroblasts are mediated via MEK/ERK and caveolin-1 signaling. J. Biol. Chem. 280(14), 13879–13887 (2005).
   PubMed Web of Science ®Google Scholar
• Mathew R. Cell-specific dual role of caveolin-1 in pulmonary hypertension. Pulm. Med. 2011, 573432 (2011).
   Google Scholar
• Mathew R, Huang J, Shah M, Patel K, Gewitz M, Sehgal PB. Disruption of endothelial-cell caveolin-1alpha/raft scaffolding during development of monocrotaline-induced pulmonary hypertension. Circulation 110(11), 1499–1506 (2004).
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay S, Xu F, Sehgal PB. Aberrant cytoplasmic sequestration of eNOS in endothelial cells after monocrotaline, hypoxia, and senescence: live-cell caveolar and cytoplasmic NO imaging. Am. J. Physiol. Heart Circ. Physiol. 292(3), H1373–1389 (2007).
   Google Scholar
• Zhao YY, Liu Y, Stan RV et al. Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc. Natl Acad. Sci. USA 99(17), 11375–11380 (2002).
   Web of Science ®Google Scholar
• Zhao YY, Zhao YD, Mirza MK et al. Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration. J. Clin. Invest. 119(7), 2009–2018 (2009).
   PubMed Web of Science ®Google Scholar
• Wunderlich C, Schmeisser A, Heerwagen C et al. Chronic NOS inhibition prevents adverse lung remodeling and pulmonary arterial hypertension in caveolin-1 knockout mice. Pulm. Pharmacol. Ther. 21(3), 507–515 (2008).
   PubMed Web of Science ®Google Scholar